Twitter v. Elon Musk
An interview with Prof. Eric Talley
CLE Credit — Approved in 4 States
The legal confrontation between Twitter and Elon Musk over Musk's attempt to acquire the social media giant has captivated public and legal communities alike, drawing attention to the intricate legal frameworks that govern mergers and acquisitions. This case is not just about the high stakes of corporate control, but also about the role of legal doctrines in regulating unexpected turns in billion-dollar deals. In this conversation, Professor Eric Talley of Columbia Law School delves into the unique aspects of this high-profile transaction and the broader implications of Musk's bid, examining both the procedural and substantive challenges that emerged.
A central issue in the Musk-Twitter saga is the use of the "poison pill" defense, a tactic employed by Twitter's board to fend off Musk's unsolicited offer. Poison pills are designed to make a hostile takeover prohibitively expensive or complicated, forcing would-be acquirers to negotiate with the board rather than directly with shareholders. Professor Talley provides a detailed examination of how poison pills operate, why they are used, and their effectiveness in modern corporate governance. This discussion not only highlights the strategic maneuvers in this case but also contextualizes them within the broader landscape of hostile takeovers.
Another pivotal aspect of the case is the concept of "material adverse effect" (MAE), which Musk attempted to use as a justification to back out of the deal. MAEs are contractual clauses that allow a party to withdraw from a deal if significant negative changes occur in the target company. Professor Talley explores the legal standards applied to MAEs, the evidentiary challenges they present, and how they were argued in the context of this transaction. His analysis offers a clear example of why proving an MAE can be an uphill battle and the role this doctrine plays in M&A litigation.
The implications of the Twitter v. Musk case extend beyond the specific legal issues it raises. This case underscores the growing importance of legal strategies in high-stakes corporate transactions and the need for legal practitioners to navigate complex negotiations and dispute resolutions effectively. Professor Talley discusses how this case might influence future M&A practices, particularly in dealing with volatile markets and unconventional buyers like Musk, who bring unique challenges to the negotiation table.
Professor Eric Talley holds a Ph.D. in Economics from Stanford and teaches at Columbia Law School, specializes in corporate law, with a focus on mergers and acquisitions.
Additional Resources
Select Cases Discussed
Selectica, Inc. v. Versata Enterprises, Inc., et al. – Delaware Court of Chancery (2010)
Snow Phipps Group, LLC v. KCAKE Acquisition, Inc, et al. – Delaware Court of Chancery (2021)
Select M&A Terms Discussed
- Standstill Agreement. A standstill agreement may be used as a form of defense to a takeover disfavored by the board when a target company acquires a promise from a bidder to limit the amount of stock that the bidder buys or holds in the target company in exchange for certain rights or benefits to the shareholder.
- Tender Offer. A tender offer is a public bid for stockholders to sell their stock. Typically, a tender offer is commenced when the company making the offer – the bidder – places a summary advertisement, or “tombstone,” in a major national newspaper and the offer to purchase is printed and mailed to the target company’s stockholders. A tender offer must comply with the rules and regulations of the SEC, which include certain disclosure requirements, minimum offering periods, withdrawal rights, manner of publication, and other requirements.
- Poison Pill. A poison pill is a tool used by corporate boards to make an acquisition intolerably expensive. The way that a poison pill works is by setting a trigger or threshold in the terms of stock ownership which, if reached or surpassed by a particular shareholder, will result in the dilution of that shareholder's interest in the company. For example if a company could set its poison pill trigger at 15% of the company’s stock. If a shareholder then purchases for example 17% position in the company, the company may then make significant quantities of stock available for purchase to all other shareholders at a reduced price or even at no cost at all. This can both make the potential acquisition more expensive and at the same time significantly dilute the potential acquirer's share and devalue their investment.
- Reverse Triangular Merger. A reverse triangular merger is a type of merger where the buyer forms a subsidiary which it then uses to merge with the target company (“the target”). The target then absorbs the buyer subsidiary which no longer exists as a separate legal entity. The target services as the buyers subsidiary.
- Material Adverse Effect. In acquisition agreements, Material Adverse Effect (“MAE”) provisions can allow a party to walk away from a signed deal if certain types of material changes have occurred at the company. These provisions typically come with a list of exceptions such as recessions, wars, earthquakes, and now pandemics, and are narrowly interpreted by courts.
- Bring-Down. A bring-down condition is a closing condition reaffirming the accuracy of the representations and warranties from an agreement at the time of the closing. Reps and warranties can in some cases be signed months in advance of closing.
- Big Boy Clause or Big Boy Letter. A “big boy” letter or clause is a pre-sale agreement in connection with a sale not to sue over non-disclosure of material inside information that is not disclosed, entered into between two sophisticated parties. Big boy provisions may also be contained within securities purchase agreements, rather than being the subject of a separate letter agreement.
- CFIUS. The Committee on Foreign Investment in the United States (CFIUS) assesses the potential national security risks of investments in the U.S. and operates in a classified environment.
About Prof. Eric Talley
“It may be easier to list what's not exceptional about this transaction... ”
Eric Talley is a professor of law at Columbia Law School. He is an expert on the intersection of corporate law, governance, and finance. He teaches and researches in the areas of mergers and acquisitions, quantitative methods, machine learning, contract and commercial law, alternative investments, game theory, and economic analysis of law. He also serves as the co-director of the Ira M. Millstein Center for Global Markets and Corporate Ownership.Talley is a Research Member of the European Corpo rate Governance Institute and serves on the Executive Committee of the Columbia University Data Science Institute. He also serves (or has served) as a director on the boards of the Society for Empirical Legal Studies and the American Law and Economics Association.
